Risk of heart failure among postmenopausal women a secondary analysis of the randomized trial of Vitamin D plus calcium of the women's health initiative

Circulation: Heart Failure

Volumn 8, Issue 1, 2015, Pages 49-56

  Donneyong, Macarius M ^a,b   Hornung, Carlton A ^b   Taylor, Kira C ^b   Baumgartner, Richard N ^b   Myers, John A ^a   Eaton, Charles B ^c   Gorodeski, Eiran Z ^d   Klein, Liviu ^e   Martin, Lisa W ^f   Shikany, James M ^g   Song, Yiqing ^h   Li, Wenjun ⁱ   Manson, JoAnn E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c BROWN UNIVERSITY   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

^g University of Alabama at Birmingham   (United States)

^h INDIANA UNIVERSITY   (United States)

ⁱ UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Calcium; Clinical trial; Heart failure; Vitamin D; Women

Indexed keywords

CALCIUM; VITAMIN D; CALCIUM INTAKE; VITAMIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; FOLLOW UP; HEART FAILURE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCIDENCE; INTENTION TO TREAT ANALYSIS; ISCHEMIC HEART DISEASE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADMINISTRATION AND DOSAGE; CALCIUM INTAKE; DIETARY SUPPLEMENT; EXERCISE; EXERCISE TEST; HEMODYNAMICS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WOMEN'S HEALTH;

AGED; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEMODYNAMICS; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAMIN D; VITAMINS; WOMEN'S HEALTH;

EID: 84927737473     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001738     Document Type: Article

References (34)

1. Ramani GV, Uber PA, Mehra MR. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc. 2010;85:180-195. doi: 10.4065/mcp.2009.0494.
2. Nemerovski CW, Dorsch MP, Simpson RU, Bone HG, Aaronson KD, Bleske BE. Vitamin D and cardiovascular disease. Pharmacotherapy. 2009;29:691-708. doi: 10.1592/phco.29.6.691.
3. Witham MD. Vitamin D in chronic heart failure. Curr Heart Fail Rep. 2011;8:123-130. doi: 10.1007/s11897-011-0048-6.
4. Lavie CJ, Lee JH, Milani RV. Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol. 2011;58:1547-1556. doi: 10.1016/j.jacc.2011.07.008.
5. Achinger SG, Ayus JC. The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl. 2005:S37-S42.
6. Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T, Trikalinos TA. Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep). 2009;183:1-420.
7. Drüeke TB, McCarron DA. Paricalcitol as compared with calcitriol in patients undergoing hemodialysis. N Engl J Med. 2003;349:496-499. doi: 10.1056/NEJMe038104.
8. Rostand SG, Drüeke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 1999;56:383-392. doi: 10.1046/j.1523-1755.1999.00575.x.
9. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant. 2004;19:179-184.
10. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr, Thadhani R. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol. 2005;16:1115-1125. doi: 10.1681/ASN.2004070573.
11. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. doi: 10.1136/bmj.c3691.
12. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010;152:315-323. doi: 10.7326/0003-4819-152-5-201003020-00010.
13. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M; Women's Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846-854. doi: 10.1161/ CIRCULATIONAHA.106.673491.
14. Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev. 2000;5:167-173. doi: 10.1023/A:1009884820941.
15. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Krstic G, Wetterslev J, Gluud C. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011: CD007470.
16. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307-314. doi: 10.7326/0003-4819-152-5-201003020-00009.
17. Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med. 2010;51:228-233. doi: 10.1016/j.ypmed.2010.06.013.
18. Xu R, O'Quigley J. Estimating average regression effect under nonproportional hazards. Biostatistics. 2000;1:423-439. doi: 10.1093/ biostatistics/1.4.423.
19. Jackson RD, LaCroix AZ, Cauley JA, McGowan J. The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003;13(9 suppl):S98-S106.
20. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL. Implementation of the Women's Health Initiative study design. Ann Epidemiol. 2003;13(9 suppl):S5-S17.
21. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FaNB. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC, 1999.
22. Heckbert SR, Kooperberg C, Safford MM, Psaty BM, Hsia J, McTiernan A, Gaziano JM, Frishman WH, Curb JD. Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol. 2004;160:1152-1158. doi: 10.1093/aje/.
23. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW; American College of Cardiology Foundation; American Heart Association. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53:e1-e90. doi: 10.1016/j.jacc.2008.11.013.
24. Hintze J. NCSS 9. NCSS, LLC. Kaysville, UT. 2013. www.ncss.com. Accessed January 23, 2014.
25. Weiliang Q, Jorge C, Ross L, Bernard R, Jing M. powerSurvEpi (v 0.06): Power and Sample Size Calculation for Survival Analysis of Epidemiological Studies. Boston, MA. 2012. http://cran.r-project.org/ web/packages/powerSurvEpi/. Accessed May 27, 2014.
26. Heinze MKaG. PSHREG: A SAS Macro for Proportional and Nonproportional Subdistribution Hazards Regression With Competing Risk Data. Vienna: Medical University of Vienna. 2012.
27. Brunner R, Dunbar-Jacob J, Leboff MS, Granek I, Bowen D, Snetselaar LG, Shumaker SA, Ockene J, Rosal M, Wactawski-Wende J, Cauley J, Cochrane B, Tinker L, Jackson R, Wang CY, Wu L. Predictors of adherence in the Women's Health Initiative Calcium and Vitamin D Trial. Behav Med. 2009;34:145-155. doi: 10.3200/BMED.34.4.145-155.
28. Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M; RECORD Trial Group. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr. 2014;100:746-755. doi: 10.3945/ajcn.113.082602.
29. Walters MR, Ilenchuk TT, Claycomb WC. 1,25-Dihydroxyvitamin D3 stimulates 45Ca2+ uptake by cultured adult rat ventricular cardiac muscle cells. J Biol Chem. 1987;262:2536-2541.
30. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation. 1996;94:2285-2296.
31. Xiang W1, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab. 2005; 288:E125-132.
32. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229-238. doi: 10.1172/JCI15219.
33. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010;55:1283-1288. doi: 10.1161/HYPERTENSIONAHA. 109.148619.
34. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, März W. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta. 2010;411:1354-1360. doi: 10.1016/j.cca.2010.05.037.